Skip to main content

Table 3 ANOVA table for USP plate count

From: A Design of Experiment (DoE) based approach for development and optimization of nanosuspensions of telmisartan, a BCS class II antihypertensive drug

Source

Sum of squares

df

Mean square

F value

p value

 

Model

2.076 + 005

3

69200.48

28.19

0.0003

Significant

 A-FR

32501.03

1

32501.03

13.24

0.0083

 B-pH

1.346E+005

1

1.346E+005

58.43

0.0001

 AB

40474.39

1

40474.39

16.49

0.0048

 Curvature

6.137E+005

1

6.137E+005

249.99

< 0.0001

Pure error

17185.85

7

2455.12

  

Cor total

8.385E+005

11